Schedule 13G ownership disclosure

Cannabics Pharmaceuticals Inc

Security class unavailable · CUSIP: 13764M209

Event date: 2022-11-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
238,980
Percent of class
9.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-23-000250
Form type
SC 13G
Filer
3i, LP
CIK
CIK 1841619
Filed
Mar 06, 2023
Reporting period
Nov 11, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub